NCT01236027已完成不适用
Collection of Biological Specimens for Development and Validation of Laboratory Procedures to Support Future Clinical Research Studies
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 245
- 试验地点
- 1
- 主要终点
- Validation of Laboratory Procedures
研究概览
简要总结
Biologic samples are necessary for development and validation of laboratory procedures (e.g. novel biological and analytical assays, explant tissue models, validation of specimen collection and transport) to support future infectious disease clinical studies. In this research study, the investigators will collect blood samples, vaginal swabs, cervical swabs, mucus/vaginal discharge, cervicovaginal lavages, vaginal and cervical biopsies, as necessary, to use in the development of laboratory processes. The investigators will obtain the sample(s) from healthy HIV negative women. Samples will be collected and sent to Magee-Womens Research Institute as laboratory specimens are needed.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Control Group (post-menopausal) Inclusion:
- •Females, age greater than 50 years
- •Non-pregnant
- •Post-menopausal defined as no menses or vaginal bleeding for at least 1 year
- •Agree to have HIV testing or have documentation of a negative HIV test result within the past 6 months.
- •Free from participant report and clinician observed abnormal discharge or other vaginal symptoms (with the exception of vaginal dryness) on the day of genital sample collection.
- •Willing and able to provide written informed consent.
- •Willing to provide contact information for receipt of laboratory results, as applicable.
- •Reproductive-aged Group Inclusion Criteria:
- •Females, 18-45 years of age
- •Non-pregnant
- •Agree to have HIV testing or have documentation of a negative HIV test result within the past 6 months.
- •Free from participant reports and clinician observed abnormal vaginal discharge or other current vaginal symptoms on the day of genital sample collection.
- •Willing and able to provide written informed consent.
- •Willing to provide contact information for receipt of laboratory results, as applicable.
- •Participant meets requirements of specific laboratory study needs (e.g. birth control method and length of use)
排除标准
- •Control Group (post-menopausal) Exclusion Criteria:
- •Use of hormone replacement therapy, including oral, vaginal and transdermal.
- •Hysterectomy.
- •An active urogenital infection within the past 14 days, including:
- •Vaginal infections (symptomatic candidiasis, trichomonas vaginalis, and bacterial vaginosis).
- •Cervical infections (Gonorrhea (GC), Chlamydia (CT) or mucopurulent cervicitis (MPC)).
- •HSV/Genital Warts
- •Urinary Tract Infection
- •Recent exposure to a partner with GC, CT, trichomonas, syphilis, non-gonococcal urethritis, or HIV.
- •Use of systemic or vaginal antibiotics or antifungals 14 days prior to genital sample collection.
- •Participation in a microbicide or other vaginal product study within one month of genital sample collection.
- •Use of a spermicide or spermicidally lubricated condom within one week prior to genital sample collection.
- •Use of an internal vaginal device or product with the exception of tampons within one week of genital sample collection.
- •Any other condition in the opinion of the site investigator would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data or otherwise interfere with achieving study objectives.
- •Reproductive-aged Group Exclusion Criteria:
- •Menopausal (including natural menopause defined as lack of menses for 12 consecutive months, in the absence of pregnancy, and surgical menopause defined as a woman who has had both ovaries removed).
- •Currently pregnant (or has been pregnant within the past 90 days) or breastfeeding
- •Hysterectomy.
- •Use of a diaphragm or NuvaRing for contraception or use of spermicide for primary contraception.
- •An active urogenital infection within the past 14 days, including:
- •Vaginal infections (symptomatic candidiasis, Trichomonas vaginalis and bacterial vaginosis).
- •Cervical infections (Gonorrhea (GC), Chlamydia (CT) or Mucopurulent cervicitis (MPC).
- •HSV/Genital Warts
- •Urinary Tract Infection
- •Recent exposure to a partner with GC, CT, Trichomonas, syphilis, Non-gonococcal urethritis or HIV.
- •Use of systemic or vaginal antibiotics or antifungals 14 days prior to genital sample collection.
- •Participation in a microbicide and/or contraceptive study within one month of genital sample collection.
- •Use of a spermicide or spermicidally lubricated condom within one week prior to genital sample collection.
- •Use of an internal vaginal device or product with the exception of tampons within one week of genital sample collection.
- •Any other condition in the opinion of the site investigator would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data or otherwise interfere with achieving the study objectives.
结局指标
主要结局
Validation of Laboratory Procedures
时间窗: up to 5 years
The primary aim of this study is to collect an adequate number of biological samples, as needed by investigators, to support development and validation of laboratory procedures necessary for upcoming topical microbicide and infectious disease research clinical trials.
次要结局
未报告次要终点
研究者
Katherine Bunge
Assistant Professor
University of Pittsburgh
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersNeoplasmsHematologic NeoplasmsHealthy VolunteersNCT00071045National Heart, Lung, and Blood Institute (NHLBI)6,000
已完成
4 期
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)Hepatosplenic T-Cell LymphomaNCT01804166Janssen Scientific Affairs, LLC1
招募中
不适用
Development of a Biological Database in the Field of Operative Intensive CareIntensive Care in GeneralNCT03014427RWTH Aachen University99,999,999
招募中
不适用
Infectious Prospective Collection for Biological AnalysisInfectious DiseaseNCT06159270CerbaXpert22,870
已完成
不适用
Biological Specimen Collection for Laboratory Methods Development and Training PurposesHealthyNCT00025831National Cancer Institute (NCI)200